{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T02:25:30Z","timestamp":1777861530971,"version":"3.51.4"},"reference-count":25,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T00:00:00Z","timestamp":1777507200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To investigate the impact of blood glucose control levels on cardiac function recovery and long-term prognosis in elderly patients with acute myocardial infarction (AMI) undergoing percutaneous coronary intervention (PCI).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Method<\/jats:title>\n                    <jats:p>\n                      A retrospective study included 80 elderly AMI patients from January 2023 to January 2024, divided into good (HbA1c\u2009\u2264\u20097%,\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200939) and poor (HbA1c\u2009&amp;gt;\u20097%,\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200941) baseline glucose control groups. Further, based on HbA1c at 3 months post-PCI, patients were classified into four groups: continuous good control (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200934), postoperative improvement (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200915), postoperative deterioration (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u20095), and persistent poor control (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200926). Outcomes compared included MACE, stent thrombosis, cardiovascular readmission, NYHA class improvement, eGFR decline &amp;gt;20%, LVEF, and quality of life scores. Patients were prospectively followed at 3, 6, and 12 months after PCI via standardized telephone interviews or in-person outpatient visits to assess glycemic control (HbA1c, fasting glucose), cardiac function (LVEF, NYHA class), MACE, renal function, and quality of life (SF-36).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Result<\/jats:title>\n                    <jats:p>\n                      The poor baseline control group had higher diabetes prevalence (78.05% vs. 20.51%,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&amp;lt;\u20090.001) and more frequent use of metformin and insulin. Group 4 had the highest MACE incidence (34.62%), lowest mean LVEF (45.3\u2009\u00b1\u20096.1%), worst renal function preservation, and lowest quality of life. Group 3 showed increased MACE risk (20%). In contrast, Group 2, achieving glucose control postoperatively, had a prognosis similar to Group 1.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Continuous blood glucose management after PCI significantly improves prognosis in elderly AMI patients. Dynamic monitoring provides greater clinical value than baseline control alone.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fcvm.2026.1644294","type":"journal-article","created":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T04:23:20Z","timestamp":1777523000000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Impact of hypoglycemic regimens on cardiac recovery and quality of life after PCI in elderly AMI patients"],"prefix":"10.3389","volume":"13","author":[{"given":"Lei","family":"Qian","sequence":"first","affiliation":[{"name":"Department of Cardiology, The Affiliated Cardiovascular Hospital of Qingdao University","place":["Qingdao, Shandong, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ping","family":"Zhou","sequence":"additional","affiliation":[{"name":"Trauma and Neurosurgery Department, Women and Children\u2019s Hospital, Qingdao University","place":["Qingdao, Shandong, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhimin","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Hongsen Hospital, Harbin Medical University","place":["Sanya, Hainan, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,4,30]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"83","DOI":"10.59249\/LSWK8578","article-title":"Arrhythmias after acute myocardial infarction","volume":"96","author":"Frampton","year":"2023","journal-title":"Yale J Biol Med"},{"key":"B2","doi-asserted-by":"publisher","first-page":"101327","DOI":"10.1016\/j.cpcardiol.2022.101327","article-title":"Acute myocardial infarction in pregnancy","volume":"47","author":"Gedeon","year":"2022","journal-title":"Curr Probl Cardiol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"222","DOI":"10.2478\/rjim-2022-0012","article-title":"The role of Tei index added to the GRACE risk score for prediction of in-hospital MACE after acute myocardial infarction","volume":"60","author":"Dalimunthe","year":"2022","journal-title":"Rom J Intern Med"},{"key":"B4","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1002\/ejhf.3548","article-title":"Empagliflozin in acute myocardial infarction in patients with and without type 2 diabetes: a pre-specified analysis of the EMPACT-MI trial","volume":"27","author":"Petrie","year":"2025","journal-title":"Eur J Heart Fail"},{"key":"B5","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/s13098-024-01306-y","article-title":"Predictive effect of triglyceride-glucose index on no-reflow phenomenon in patients with type 2 diabetes mellitus and acute myocardial infarction undergoing primary percutaneous coronary intervention","volume":"16","author":"Ma","year":"2024","journal-title":"Diabetol Metab Syndr"},{"key":"B6","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s12916-023-02781-2","article-title":"SGLT-2 inhibitors and in-stent restenosis-related events after acute myocardial infarction: an observational study in patients with type 2 diabetes","volume":"21","author":"Marfella","year":"2023","journal-title":"BMC Med"},{"key":"B7","doi-asserted-by":"publisher","first-page":"333","DOI":"10.5114\/aic.2023.133475","article-title":"Serum oxidative stress factors predict myocardial ischemia reperfusion injury after percutaneous coronary intervention in patients with acute myocardial infarction and type 2 diabetes mellitus","volume":"19","author":"Zhao","year":"2023","journal-title":"Postepy Kardiol Interwencyjnej"},{"key":"B8","doi-asserted-by":"publisher","first-page":"e771","DOI":"10.1161\/CIR.0000000000001328","article-title":"2025 ACC\/AHA\/ACEP\/NAEMSP\/SCAI guideline for the management of patients with acute coronary syndromes: a report of the American college of cardiology\/American heart association joint committee on clinical practice guidelines","volume":"151","author":"Rao","year":"2025","journal-title":"Circulation"},{"key":"B9","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1007\/s10840-024-01900-0","article-title":"Mid-term clinical outcomes and cardiac function in patients receiving cardiac contractility modulation","volume":"68","author":"Deak","year":"2025","journal-title":"J Interv Card Electrophysiol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"2116","DOI":"10.1002\/jor.24944","article-title":"Minimal clinically important differences in SF-36 global score: current value in orthopedic oncology","volume":"39","author":"Ogura","year":"2021","journal-title":"J Orthop Res"},{"key":"B11","doi-asserted-by":"publisher","first-page":"8504","DOI":"10.3390\/ijms25158504","article-title":"Acute hyperglycemia-induced injury in myocardial infarction","volume":"25","author":"Pepe","year":"2024","journal-title":"Int J Mol Sci"},{"key":"B12","doi-asserted-by":"publisher","first-page":"932716","DOI":"10.3389\/fcvm.2022.932716","article-title":"Association of admission hyperglycemia and all-cause mortality in acute myocardial infarction with percutaneous coronary intervention: a dose-response meta-analysis","volume":"9","author":"Cheng","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"B13","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1186\/s12933-024-02365-1","article-title":"Trends in prognosis and use of SGLT2i and GLP-1 RA in patients with diabetes and coronary artery disease","volume":"23","author":"Ritsinger","year":"2024","journal-title":"Cardiovasc Diabetol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1923","DOI":"10.1056\/NEJMc2311551","article-title":"Complete or culprit-only PCI in older patients with MI","volume":"389","author":"Mone","year":"2023","journal-title":"N Engl J Med"},{"key":"B15","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1186\/s12933-024-02201-6","article-title":"Association between diabetes mellitus and primary restenosis following endovascular treatment: a comprehensive meta-analysis of randomized controlled trials","volume":"23","author":"Sun","year":"2024","journal-title":"Cardiovasc Diabetol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1186\/s12933-025-02733-5","article-title":"Long-term impact of diabetes on mortality in patients undergoing unprotected left main PCI: a propensity score-matched analysis from the BIA-LM registry","volume":"24","author":"Kralisz","year":"2025","journal-title":"Cardiovasc Diabetol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1002\/jcph.6149","article-title":"Efficacy and safety of SGLT-2 inhibitors in acute myocardial infarction: a systematic review and meta-analysis","volume":"65","author":"Asham","year":"2025","journal-title":"J Clin Pharmacol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"154","DOI":"10.31083\/j.rcm2505154","article-title":"Effect of SGLT-2 inhibitors on prognosis in diabetic patients with acute myocardial infarction: a systematic review and meta-analysis","volume":"25","author":"Li","year":"2024","journal-title":"Rev Cardiovasc Med"},{"key":"B19","doi-asserted-by":"publisher","first-page":"2004","DOI":"10.2337\/dc23-0671","article-title":"Comparative cardiovascular effectiveness and safety of SGLT-2 inhibitors, GLP-1 receptor agonists, and DPP-4 inhibitors according to frailty in type 2 diabetes","volume":"46","author":"Kutz","year":"2023","journal-title":"Diabetes Care"},{"key":"B20","doi-asserted-by":"publisher","first-page":"113606","DOI":"10.1016\/j.biopha.2022.113606","article-title":"Novel cardioprotective mechanism for empagliflozin in nondiabetic myocardial infarction with acute hyperglycemia","volume":"154","author":"Deng","year":"2022","journal-title":"Biomed Pharmacother"},{"key":"B21","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/j.tcm.2023.11.006","article-title":"Prognostic value of stress hyperglycemia ratio in patients with acute myocardial infarction: a systematic review with Bayesian and frequentist meta-analysis","volume":"34","author":"Karakasis","year":"2024","journal-title":"Trends Cardiovasc Med"},{"key":"B22","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.jdiacomp.2010.01.001","article-title":"High-dose insulin in experimental myocardial infarction in rabbits: protection against effects of hyperglycaemia","volume":"25","author":"Wong","year":"2011","journal-title":"J Diabetes Complications"},{"key":"B23","doi-asserted-by":"publisher","first-page":"7797","DOI":"10.2147\/IJGM.S294896","article-title":"Long-term pharmacological management of reduced ejection fraction following acute myocardial infarction: current Status and future prospects","volume":"14","author":"Abel","year":"2021","journal-title":"Int J Gen Med"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1007\/s00392-023-02366-2","article-title":"GLP-1 in patients with myocardial infarction complicated by cardiogenic shock-an IABP-SHOCK II-substudy","volume":"113","author":"Lehrke","year":"2024","journal-title":"Clin Res Cardiol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1186\/s12933-025-02868-5","article-title":"Prognostic impact of type 2 diabetes mellitus and coronary microvascular dysfunction in patients undergoing rotational atherectomy during PCI","volume":"24","author":"Feng","year":"2025","journal-title":"Cardiovasc Diabetol"}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2026.1644294\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T04:23:24Z","timestamp":1777523004000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2026.1644294\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,30]]},"references-count":25,"alternative-id":["10.3389\/fcvm.2026.1644294"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2026.1644294","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,30]]},"article-number":"1644294"}}